TELA Bio, Inc. (TELA) Operating Margin
- Operating margin · 12 months: Value -42.56%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -42.56% | Operating income / revenue. Period ending 2026-06-30. $-34.01M ÷ $79.91M × 100 ≈ -42.56% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -34.01M USD | Operating Income (Loss) |
| Revenue | 79.91M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 9.54M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-34.01M | $79.91M | (m) | $9.54M | (m) | -42.56% |
| 2026-03-31 | $-33.81M | $80.81M | (m) | $9.02M | (m) | -41.84% |
| 2025-12-31 | $-33.76M | $80.28M | (m) | $9.22M | (m) | -42.05% |
| 2025-09-30 | $-35.46M | $77.06M | (m) | $9.12M | (m) | -46.02% |
| 2025-06-30 | $-37.27M | $75.32M | (m) | $8.84M | (m) | -49.48% |
| 2025-03-31 | $-39.76M | $71.22M | (m) | $8.96M | (m) | -55.83% |
| 2024-12-31 | $-34.12M | $69.30M | (m) | $8.81M | (m) | -49.23% |
| 2024-09-30 | $-38.04M | $68.65M | (m) | $9.47M | (m) | -55.41% |
| 2024-06-30 | $-38.85M | $64.74M | (m) | $9.77M | (m) | -60.01% |
| 2024-03-31 | $-37.65M | $63.15M | (m) | $9.96M | (m) | -59.62% |
| 2023-12-31 | $-44.08M | $58.45M | (m) | $9.62M | (m) | -75.40% |
| 2023-09-30 | $-41.24M | $53.08M | (m) | $9.66M | (m) | -77.69% |
| 2023-06-30 | $-40.54M | $49.18M | (m) | $9.39M | (m) | -82.43% |
| 2023-03-31 | $-40.42M | $45.10M | (m) | $8.98M | (m) | -89.62% |
| 2022-12-31 | $-39.01M | $41.42M | (m) | $8.94M | (m) | -94.18% |
| 2022-09-30 | $-37.22M | $38.17M | (m) | $7.94M | (m) | -97.52% |
| 2022-06-30 | $-34.95M | $34.66M | (m) | $7.24M | (m) | -100.83% |
| 2022-03-31 | $-32.03M | $31.82M | (m) | $7.07M | (m) | -100.66% |
| 2021-12-31 | $-29.45M | $29.46M | (m) | $6.74M | (m) | -99.96% |
| 2021-09-30 | $-28.54M | $26.76M | (m) | $6.18M | (m) | -106.68% |
| 2021-06-30 | $-28.19M | $24.41M | (m) | $5.97M | (m) | -115.46% |
| 2021-03-31 | $-26.05M | $20.36M | (m) | $5.02M | (m) | -127.90% |
| 2020-12-31 | $-25.27M | $18.21M | (m) | $4.25M | (m) | -138.77% |
| 2020-09-30 | $-24.35M | $17.41M | (m) | $4.01M | (m) | -139.89% |
| 2020-06-30 | $-21.35M | $16.07M | (m) | $3.33M | (m) | -132.84% |
| 2020-03-31 | $-20.48M | $15.87M | (m) | $3.40M | (m) | -129.09% |
| 2019-12-31 | $-19.16M | $15.45M | (m) | $4.15M | (m) | -124.06% |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $-17.78M | $8.27M | (m) | $4.34M | (m) | -214.91% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-16.92M | $4.25M | (m) | $5.79M | (m) | -398.68% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |